DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ slipped 2.32% to $55.53 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.67% to 6,066.44 and the Dow Jones Industrial Average rising 0.38% to 44,470.41.
This was the stock's third consecutive day of losses.
Bristol Myers Squibb Co. closed 9.12% below its 52-week high of $61.10, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.73% to $154.24, Pfizer Inc. $(PFE)$ rose 0.51% to $25.87, and Abbott Laboratories $(ABT)$ rose 1.74% to $131.31.
Trading volume (16.6 M) eclipsed its 50-day average volume of 10.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 10, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 10, 2025 16:38 ET (21:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.